grant
saveVELAKOR BIOTHERAPEUTICS, INC. — Proof of concept and dose response of CAM-6019 for HFrEF patients
September 15, 2025updated 2mo ago
community read0 votes
HL grant. $2,095,748. PI: Kfir Umansky
view source ↗HL grant. $2,095,748. PI: Kfir Umansky
view source ↗
comments(0)
5-min edit window · permanent after that